TOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugs
(Alliance News) - GSK PLC on Wednesday restructured an existing collaboration with CureVac NV into a new licensing agreement to take control of developing a number of flu and Covid drugs. Read More